Bis(4,4′‐dimethyl‐2,2′‐bipyridine) ruthenium (II) Complexes Containing 2‐Arylimidazo‐ [4,5‐f] [1,10] phenanthroline: Syntheses,Characterization and Third‐order Nonlinear Optical Properties

Four novel mononuclear ruthenium(II) complexes [Ru(dmb)₂L]²⁺ [dmb = 4,4′‐dimethyl‐2,2′‐bipyridine, L = imidazo‐[4,5‐f][1,10]phenanthroline (IP), 2‐phenylimidazo‐[4,5‐f][1,10]phenanthroline (PIP), 2‐(4′‐hydroxyphenyl)imidazo‐[4,5‐f] [1,10] phenanthroline (HOP), 2‐(4′‐dimethylaminophenyl) imidazo‐[4, 5‐f] [1,10] phenanthroline (DMNP)] were synthesized and characterized by ES‐MS, ¹H NMR, UV‐vis and electrochemistry. The nonlinear optical properties of the ruthenium(II) complexes were investigated by Z‐scan techniques with 12 ns laser pulse at 540 nm, and all of them exhibit both nonlinear optical (NLO) absorption and self‐defocusing effect. The corresponding effective NLO susceptibility |x³| of the complexes is in the range of 2.68 × 10^?12‐4.57 × 10^?12 esu.     

Synthesis and structures of ruthenium di‐ and tricarbonyl complexes derived from 4,5‐diazafluoren‐9‐one

Carbon monoxide (CO) has recently been shown to impart beneficial effects in mammalian physiology and considerable research attention is now being directed toward metal–carbonyl complexes as a means of delivering CO to biological targets. Two ruthenium carbonyl complexes, namely trans‐dicarbonyldichlorido(4,5‐diazafluoren‐9‐one‐κ²N,N′)ruthenium(II), [RuCl₂(C₁₁H₆N₂O)(CO)₂], (1), and fac‐tricarbonyldichlorido(4,5‐diazafluoren‐9‐one‐κN)ruthenium(II), [RuCl₂(C₁₁H₆N₂O)(CO)₃], (2), have been isolated and structurally characterized. In the case of complex (1), the trans‐directing effect of the CO ligands allows bidentate coordination of the 4,5‐diazafluoren‐9‐one (dafo) ligand despite a larger bite distance between the N‐donor atoms. In complex (2), the cis disposition of two chloride ligands restricts the ability of the dafo molecule to bind ruthenium in a bidentate fashion. Both complexes exhibit well defined ¹H NMR spectra confirming the diamagnetic ground state of Ru^II and display a strong absorption band around 300 nm in the UV.     

Synthesis,Characterization, and DNA Interaction Studies of the Ruthenium(II) Complexes [Ru(bpy)2(ipbp)]2+ and [Ru(ipbp)(phen)2]2+ (ipbp=3‐(1H‐Imidazo[4,5‐f][1,10]phenanthrolin‐2‐yl)‐4H‐1‐benzopyran‐2‐one; bpy=2,2′‐Bipyridine; phen=1,10‐Phenanthroline)

A novel ligand 3‐(1H‐imidazo[4,5‐f][1,10]phenanthrolin‐2‐yl)‐4H‐1‐benzopyran‐4‐one (ipbp) and its ruthenium(II) complexes [Ru(bpy)₂(ipbp)]²⁺ ( 1 ) and [Ru(ipbp)(phen)₂]²⁺ ( 2 ) (bpy=2,2′‐bipyridine, phen=1,10‐phenanthroline) were synthesized and characterized by elemental analysis and mass, ¹H‐NMR, and electronic‐absorption spectroscopy. The electrochemical behavior of the complexes was studied by cyclic voltammetry. The DNA‐binding behavior of the complexes was investigated by spectroscopic methods and viscosity measurements. The results indicate that complexes 1 and 2 bind with calf‐thymus DNA in an intercalative mode. In addition, 1 and 2 promote cleavage of plasmid pBR 322 DNA from the supercoil form I to the open circular form II upon irradiation.     

Catalytic Water Oxidation by Ruthenium(II) Quaterpyridine (qpy) Complexes: Evidence for Ruthenium(III) qpy‐N,N′′′‐dioxide as the Real Catalysts

Polypyridyl and related ligands have been widely used for the development of water oxidation catalysts. Supposedly these ligands are oxidation‐resistant and can stabilize high‐oxidation‐state intermediates. In this work a series of ruthenium(II) complexes [Ru(qpy)(L)₂]²⁺ (qpy=2,2′:6′,2′′:6′′,2′′′‐quaterpyridine; L=substituted pyridine) have been synthesized and found to catalyze Ce^IV‐driven water oxidation, with turnover numbers of up to 2100. However, these ruthenium complexes are found to function only as precatalysts; first, they have to be oxidized to the qpy‐N,N′′′‐dioxide (ONNO) complexes [Ru(ONNO)(L)₂]³⁺ which are the real catalysts for water oxidation.     

Chiral Bis(oxazoline) Ruthenium Complexes with Bipyridyl‐Type N‐Heteroaromatics: Comparative Stereochemical and Photochemical Characterization of their Λ‐ and Δ‐Diastereomeric Geminate Isomers

Diastereomeric geminate pairs of chiral bis(2‐oxazoline) ruthenium complexes with bipyridyl‐type N‐heteroaromatics, Λ‐ and Δ‐[Ru(L‐ L)₂(iPr‐biox)]²⁺ (iPr‐biox=(4S,4′S)‐4,4′‐diisopropyl‐2,2′‐bis(2‐oxazoline); L‐ L=2,2′‐bipyridyl (bpy) for 1 Λ and 1 Δ, 4,4′‐dimethyl‐2,2′‐bipyridyl (dmbpy) for 2 Λ and 2 Δ, and 1,10‐phenanthroline (phen) for 3 Λ and 3 Δ), were separated as BF₄ and PF₆ salts and were subjected to the comparative studies of their stereochemical and photochemical characterization. DFT calculations of 1 Λ and 1 Δ electronic configurations for the lowest triplet excited state revealed that their MO‐149 (HOMO) and MO‐150 (lower SOMO) characters are interchanged between them and that the phosphorescence‐emissive states are an admixture of a Ru‐to‐biox charge‐transfer state and an intraligand excited state within the iPr‐biox. Furthermore, photoluminescence properties of the two Λ,Δ‐diastereomeric series are discussed with reference to [Ru(bpy)₃]²⁺.     

Novel microwave synthesis of half‐sandwich [(η6‐C6H6)Ru] complexes and an evaluation of the biological activity and biochemical reactivity

We have used a novel microwave‐assisted method to synthesize a pair of half‐sandwich ruthenium–arene–thiosemicarbazone complexes of the type [(η⁶‐C₆H₆Ru(TSC)Cl]PF₆. The thiosemicarbazone (TSC) ligands are 2‐(anthracen‐9‐ylmethylene)hydrazinecarbothioamide and 2‐(anthracen‐9‐ylmethylene)‐N‐ethylhydrazinecarbothioamide derived from 9‐anthraldehyde. The complexes are moderately strong binders of DNA, with binding constants of 10⁴ m ^?1. They are also strong binders of human serum albumin, having binding constants of the order of 10⁵ m ^?1. The complexes show some in vitro anticancer activity against human colon cancer cells, Caco‐2 and HCT‐116, with positive therapeutic indices. They did not show any activity as antibacterial agents against the organisms that were studied. Copyright © 2013 John Wiley & Sons, Ltd.     

Imine‐N‐Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p‐Cymene Anticancer Complexes: A Structure–Activity Relationship Study

A family of novel imine‐N‐heterocyclic carbene ruthenium(II) complexes of the general formula [(η⁶‐p‐cymene)Ru(C^N)Cl]PF₆⁻ (where C^N is an imine‐N‐heterocyclic carbene chelating ligand with varying substituents) have been prepared and characterized. In this imine‐N‐heterocyclic carbene chelating ligand framework, there are three potential sites that can be modified, which distinguishes this class of ligand and provides a body of flexibilities and opportunities to tune the cytotoxicity of these ruthenium(II) complexes. The influence of substituent effects of three tunable domains on the anticancer activity and catalytic ability in converting coenzyme NADH to NAD⁺ is investigated. This family of complexes displays an exceedingly distinct anticancer activity against A549 cancer cells, despite their close structural similarity. Complex 9 shows the highest anticancer activity in this series against A549 cancer cells (IC₅₀=14.36 μm ), with an approximately 1.5‐fold better activity than the clinical platinum drug cisplatin (IC₅₀=21.30 μm ) in A549 cancer cells. Mechanistic studies reveal that complex 9 mediates cell death mainly through cell stress, including cell cycle arrest, inducing apoptosis, increasing intracellular reactive oxygen species (ROS) levels, and depolarization of the mitochondrial membrane potential (MMP). Furthermore, lysosomal damage is also detected by confocal microscopy.     

Synthesis,Characterization, and DNA‐Binding Properties of the Chiral Ruthenium(II) Complexes Δ‐ and Λ‐[Ru(bpy)2(dmppd)]2+ (dmppd = 10,12‐Dimethylpteridino[6,7‐f] [1,10]phenanthroline‐11,13(10H,12H)‐dione; bpy = 2,2′‐Bipyridine)

Two novel chiral ruthenium(II) complexes, Δ‐[Ru(bpy)₂(dmppd)]²⁺ and Λ‐[Ru(bpy)₂(dmppd)]²⁺ (dmppd = 10,12‐dimethylpteridino[6,7‐f] [1,10]phenanthroline‐11,13(10H,12H)‐dione, bpy = 2,2′‐bipyridine), were synthesized and characterized by elemental analysis, ¹H‐NMR and ES‐MS. The DNA‐binding behaviors of both complexes were studied by UV/VIS absorption titration, competitive binding experiments, viscosity measurements, thermal DNA denaturation, and circular‐dichroism spectra. The results indicate that both chiral complexes bind to calf‐thymus DNA in an intercalative mode, and the Δ enantiomer shows larger DNA affinity than the Λ enantiomer does. Theoretical‐calculation studies for the DNA‐binding behaviors of these complexes were carried out by the density‐functional‐theory method. The mechanism involved in the regulating and controlling of the DNA‐binding abilities of the complexes was further explored by the comparative studies of [Ru(bpy)₂(dmppd)]²⁺ and of its parent complex [Ru(bpy)₂(ppd)]²⁺ (ppd = pteridino[6,7‐f] [1,10]phenanthroline‐11,13 (10H,12H)‐dione).     

Dinuclear Complexes of Copper(I) with Crown Ether‐containing N‐Thiophosphorylated Bis‐thioureas and 2,2′‐Bipyridine or 1,10‐Phenanthroline: Synthesis,Characterization, and Picrate Extraction Properties

Reaction of O,O′‐diisopropylthiophosphoric acid isothiocyanate (iPrO)₂P(S)NCS with 1,10‐diaza‐18‐crown‐6, 1,7‐diaza‐18‐crown‐6, or 1,7‐diaza‐15‐crown‐5 leads to the N‐thiophosphorylated bis‐thioureas N,N′‐bis[C(S)NHP(S)(OiPr)₂]‐1,10‐diaza‐18‐crown‐6 ( H₂L^I ), N,N′‐bis[C(S)NHP(S)(OiPr)₂]‐1,7‐diaza‐18‐crown‐6 ( H₂L^II ) and N,N′‐bis[C(S)NHP(S)(OiPr)₂]‐1,7‐diaza‐15‐crown‐5 ( H₂L^III ). Reaction of the potassium salts of H₂L^I–III with a mixture of CuI and 2,2′‐bipyridine ( bpy ) or 1,10‐phenanthroline ( phen ) in aqueous EtOH/CH₂Cl₂ leads to the dinuclear complexes [Cu₂(bpy)₂L^I–III] and [Cu₂(phen)₂L^I–III] . The structures of these compounds were investigated by ¹H, ³¹P{¹H} NMR spectroscopy, and elemental analysis. The crystal structures of H₂L^I and [Cu₂(phen)₂L^I] were determined by single‐crystal X‐ray diffraction. Extraction capacities of the obtained compounds in comparison to the related compounds 1,10‐diaza‐18‐crown‐6, N,N′‐bis[C(=CMe₂)CH₂P(O)(OiPr)₂]‐1,10‐diaza‐18‐crown‐6, N,N′‐bis[C(S)NHP(O)(OiPr)₂]‐1,10‐diaza‐18‐crown‐6 towards the picrate salts LiPic, NaPic, KPic. and NH₄Pic were also studied.     

(N‐{[4‐(1,3‐Benzothiazol‐2‐yl)anilino]carbonylmethyl‐κO}iminodiacetato‐κ3O,N,O′)(1,10‐phenanthroline‐κ2N,N′)cobalt(II) pentahydrate

The title compound, [Co(C₁₉H₁₅N₃O₅S)(C₁₂H₈N₂)]·5H₂O, has a moderately distorted octahedral coordination environment composed of two N atoms of a 1,10‐phenanthroline ligand and one N and three O atoms of an N‐{[4‐(1,3‐benzothiazol‐2‐yl)anilino]carbonylmethyl}iminodiacetate (ZL‐5²⁻) ligand. The ring systems of the phenanthroline and ZL‐5²⁻ ligands are coplanar and the complexes pack in layers parallel to the ab plane with the rings of adjacent complexes facing one another. The layers stack along the c axis and are linked by hydrogen bonds involving the five water solvent molecules in the asymmetric unit and O atoms of the acetate groups of the ZL‐5²⁻ ligand. This is believed to be the first crystal structure of a complex of a 2‐(4‐aminophenyl)benzothiazole ligand.     

Synthesis and characterization of new complexes of the type [Ru(CO)2Cl2 (2‐phenyl‐1,8‐naphthyridine‐kN) (2‐phenyl‐1,8‐naphthyridine‐kN′)]. Preliminary applications in homogeneous catalysis

Novel ruthenium (II) complexes were prepared containing 2‐phenyl‐1,8‐naphthyridine derivatives. The coordination modes of these ligands were modified by addition of coordinating solvents such as water into the ethanolic reaction media. Under these conditions 1,8‐naphthyridine (napy) moieties act as monodentade ligands forming unusual [Ru(CO)₂Cl₂(η¹‐2‐phenyl‐1,8‐naphthyridine‐ kN )(η¹‐2‐phenyl‐1,8‐naphthyridine‐kN′)] complexes. The reaction was reproducible when different 2‐phenyl‐1,8‐naphthyridine derivatives were used. On the other hand, when dry ethanol was used as the solvent we obtained complexes with napy moieties acting as a chelating ligand. The structures proposed for these complexes were supported by NMR spectra, and the presence of two ligands in the [Ru(CO)₂Cl₂(η¹‐2‐phenyl‐1,8‐naphthyridine‐ kN )(η¹‐2‐phenyl‐1,8‐naphthyridine‐kN′)] type complexes was confirmed using elemental analysis. All complexes were tested as catalysts in the hydroformylation of styrene showing moderate activity in N,N′‐dimethylformamide. Copyright © 2008 John Wiley & Sons, Ltd.     

Binuclear dichlorido(η6‐p‐cymene)ruthenium(II) complexes with bis(nicotinate)‐ and bis(isonicotinate)‐polyethylene glycol ester ligands

Neutral binuclear ruthenium complexes 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 of the general formula [{RuCl₂(η⁶‐p‐cym)}₂ μ‐(N^∩N)] (N^∩N = bis(nicotinate)‐ and bis(isonicotinate)‐polyethylene glycol esters: (3‐py)COO(CH₂CH₂O)_nCO(3‐py) and (4‐py)COO(CH₂CH₂O)_nCO(4‐py), n =1–4), as well as mononuclear [RuCl₂(η⁶‐p‐cym)((3‐py)COO(CH₂CH₂OCH₃)‐κN)], complex 9 , were synthesized and characterized using elemental analysis and electrospray ionization high‐resolution mass spectrometry, infrared, ¹H NMR and ¹³C NMR spectroscopies. Stability of the binuclear complexes in the presence of dimethylsulfoxide was studied. Furthermore, formation of a cationic complex containing bridging pyridine‐based bidentate ligand was monitored using ¹H NMR spectroscopy. Ligand precursors, polyethylene glycol esters of nicotinic ( L1 · 2HCl– L4 · 2HCl and L9 · HCl) and isonicotinic acid dihydrochlorides ( L5 · 2HCl– L8 · 2HCl), binuclear ruthenium(II) complexes 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 and mononuclear complex 9 were tested for in vitro cytotoxicity against 518A2 (melanoma), 8505C (anaplastic thyroid cancer), A253 (head and neck tumour), MCF‐7 (breast tumour) and SW480 (colon carcinoma) cell lines. Copyright © 2014 John Wiley & Sons, Ltd.     

Synthesis,crystal structure and biological properties of a cis‐dichloridobis(diimine)copper(II) complex

The mechanisms of interaction of inorganic complexes with DNA are important in the design and development of new metal‐based drug molecules. The limitations of cis‐platin have encouraged the design and development of new metal‐based target‐specific anticancer drugs having reduced side effects. The complex cis‐dichloridobis(1,2,5‐thiadiazolo[3,4‐f][1,10]phenanthroline‐κ²N¹,N¹⁰)copper(II), [CuCl₂(C₁₂H₆N₄S)₂], has been synthesized and characterized. The complex crystallizes in the monoclinic space group C2/c. The covalent binding of the complex with DNA was studied by absorption spectroscopy. The anticancer activity of the complex on the Human Lung Carcinoma (A549) cell line was investigated by MTT assay. The complex exhibits higher toxicity than cis‐platin and induces an apoptotic mode of cell death.     

Tris(1,10‐phenanthroline‐κ2N,N′)iron(II) bis(2,4,5‐tricarboxybenzoate) monohydrate and tris(2,2′‐bipyridine‐κ2N,N′)iron(II) 2,5‐dicarboxybenzene‐1,4‐dicarboxylate–benzene‐1,2,4,5‐tetracarboxylic acid–water (1/1/2)

The title compounds, tris(1,10‐phenanthroline‐κ²N,N′)iron(II) bis(2,4,5‐tricarboxybenzoate) monohydrate, [Fe(C₁₂H₈N₂)₃](C₁₀H₅O₈)₂·H₂O, (I), and tris(2,2′‐bipyridine‐κ²N,N′)iron(II) 2,5‐dicarboxybenzene‐1,4‐dicarboxylate–benzene‐1,2,4,5‐tetracarboxylic acid–water (1/1/2), [Fe(C₁₀H₈N₂)₃](C₁₀H₄O₈)·C₁₀H₆O₈·2H₂O, (II), were obtained during an attempt to synthesize a mixed‐ligand complex of Fe^II with an N‐containing ligand and benzene‐1,2,4,5‐tetracarboxylic acid via a solvothermal reaction. In both mononuclear complexes, each Fe^II metal ion is six‐coordinated in a distorted octahedral manner by six N atoms from three chelating 1,10‐phenanthroline or 2,2′‐bipyridine ligands. In compound (I), the Fe^II atom lies on a twofold axis in the space group C2/c, whereas (II) crystallizes in the space group P2₁/n. In both compounds, the uncoordinated carboxylate anions and water molecules are linked by typical O—H...O hydrogen bonds, generating extensive three‐dimensional hydrogen‐bond networks which surround the cations.     

In‐ and Out‐of‐Cavity Interactions by Modulating the Size of Ruthenium Metallarectangles

Cationic (arene)ruthenium‐based tetranuclear complexes of the general formula [Ru₄(η⁶‐p‐cymene)₄(μ‐N∩N)₂(μ‐OO∩OO)₂]⁴⁺ were obtained from the dinuclear (arene)ruthenium complexes [Ru₂(η⁶‐p‐cymene)₂(μ‐OO∩OO)₂Cl₂] (p‐cymene=1‐methyl‐4‐(1‐methylethyl)benzene, OO∩OO=5,8‐dihydroxy‐1,4‐naphthoquinonato(2?), 9,10‐dihydroxy‐1,4‐anthraquinonato(2?), or 6,11‐dihydroxynaphthacene‐5,12‐dionato(2?)) by reaction with pyrazine or bipyridine linkers (N∩N=pyrazine, 4,4′‐bipyridine, 4,4′‐[(1E)‐ethene‐1,2‐diyl]bis[pyridine]) in the presence of silver trifluoromethanesulfonate (CF₃SO₃Ag) (Scheme). All complexes 4 – 12 were isolated in good yield as CF₃SO salts, and characterized by NMR and IR spectroscopy. The host–guest properties of the metallarectangles incorporating 4,4′‐bipyridine and (4,4′‐[(1E)‐ethene‐1,2‐diyl]bis[pyridine] linkers were studied in solution by means of multiple NMR experiments (1D, ROESY, and DOSY). The largest metallarectangles 10 – 12 incorporating (4,4′‐[(1E)‐ethene‐1,2‐diyl]bis[pyridine] linkers are able to host an anthracene, pyrene, perylene, or coronene molecule in their cavity, while the medium‐size metallarectangles 7 – 9 incorporating 4,4′‐bipyridine linkers are only able to encapsulate anthracene. However, out‐of‐cavity interactions are observed between these 4,4′‐bipyridine‐containing rectangles and pyrene, perylene, or coronene. In contrast, the small pyrazine‐containing metallarectangles 4 – 6 show no interaction in solution with this series of planar aromatic molecules.     

Synthesis and structures of photoactive rhenium carbonyl complexes derived from 2‐(pyridin‐2‐yl)‐1,3‐benzothiazole, 2‐(quinolin‐2‐yl)‐1,3‐benzothiazole and 1,10‐phenanthroline

Carbon monoxide (CO) has recently been identified as a gaseous signaling molecule that exerts various salutary effects in mammalian pathophysiology. Photoactive metal carbonyl complexes (photoCORMs) are ideal exogenous candidates for more controllable and site‐specific CO delivery compared to gaseous CO. Along this line, our group has been engaged for the past few years in developing group‐7‐based photoCORMs towards the efficient eradication of various malignant cells. Moreover, several such complexes can be tracked within cancerous cells by virtue of their luminescence. The inherent luminecscent nature of some photoCORMs and the change in emission wavelength upon CO release also provide a covenient means to track the entry of the prodrug and, in some cases, both the entry and CO release from the prodrug. In continuation of the research circumscribing the development of trackable photoCORMs and also to graft such molecules covalently to conventional delivery vehicles, we report herein the synthesis and structures of three rhenium carbonyl complexes, namely, fac‐tricarbonyl[2‐(pyridin‐2‐yl)‐1,3‐benzothiazole‐κ²N ,N ′](4‐vinylpyridine‐κN )rhenium(I) trifluoromethanesulfonate, [Re(C₇H₇N)(C₁₂H₈N₂S)(CO)₃](CF₃SO₃), ( 1 ), fac‐tricarbonyl[2‐(quinolin‐2‐yl)‐1,3‐benzothiazole‐κ²N ,N ′](4‐vinylpyridine‐κN )rhenium(I) trifluoromethanesulfonate, [Re(C₇H₇N)(C₁₆H₁₀N₂S)(CO)₃](CF₃SO₃), ( 2 ), and fac‐tricarbonyl[1,10‐phenanthroline‐κ²N ,N ′](4‐vinylpyridine‐κN )rhenium(I) trifluoromethanesulfonate, [Re(C₇H₇N)(C₁₂H₈N₂)(CO)₃](CF₃SO₃), ( 3 ). In all three complexes, the Re^I center resides in a distorted octahedral coordination environment. These complexes exhibit CO release upon exposure to low‐power UV light. The apparent CO release rates of the complexes have been measured to assess their comparative CO‐donating capacity. The three complexes are highly luminescent and this in turn provides a convenient way to track the entry of the prodrug molecules within biological targets.     

Bis­(acetato‐κ2O,O′)(2,9‐di­methyl‐1,10‐phenanthroline‐κ2N,N′)mercury(II) in two differently hydrated crystal forms

Two differently hydrated crystal forms of the title compound, viz. bis­(acetato‐κ²O,O′)(2,9‐di­methyl‐1,10‐phenanthroline‐κ²N,N′)­mercury(II), [Hg(C₂H₃O₂)₂(C₁₄H₁₂N₂)] or [HgAc₂(dmph)] [dmph is 2,3‐di­methyl‐1,10‐phenantroline (neocuproine) and Ac is acetate], (I), and tris­[bis­(acetato‐κ²O,O′)(2,9‐di­methyl‐1,10‐phenanthroline‐κ²N,N′)­mercury(II)] hexadecahydrate, [Hg(C₂H₃O₂)₂(C₁₄H₁₂N₂)]₃·16H₂O or [HgAc₂(dmph)]₃·16H₂O, (II), are presented. Both structures are composed of very simple monomeric units, which act as the building blocks of complex packing schemes stabilized by a diversity of π–π and hydrogen‐bonding interactions.     

Adducts of bis(acetylacetonato)zinc(II) with 1,10‐phenanthroline and 2,2′‐bipyridine

In each of the zinc(II) complexes bis(acetylacetonato‐κ²O,O′)(1,10‐phenanthroline‐κ²N,N′)zinc(II), [Zn(C₅H₇O₂)₂(C₁₂H₈N₂)], (I), and bis(acetylacetonato‐κ²O,O′)(2,2′‐bipyridine‐κ²N,N′)zinc(II), [Zn(C₅H₇O₂)₂(C₁₀H₈N₂)], (II), the metal center has a distorted octahedral coordination geometry. Compound (I) has crystallographically imposed twofold symmetry, with Z′ = 0.5. The presence of a rigid phenanthroline group precludes intramolecular hydrogen bonding, whereas the rather flexible bipyridyl ligand is twisted to form an intramolecular C—H...O interaction [the chelated bipyridyl ligand is nonplanar, with the pyridyl rings inclined at an angle of 13.4 (1)°]. The two metal complexes are linked by dissimilar C—H...O interactions into one‐dimensional chains. The present study demonstrates the distinct effects of two commonly used ligands, viz. 1,10‐phenanthroline and 2,2′‐bipyridine, on the structures of metal complexes and their assembly.     

Two centrosymmetric dinuclear phenanthroline–copper(II) complexes with 3,5‐dichloro‐2‐hydroxybenzoic acid and 5‐chloro‐2‐hydroxybenzoic acid

The title compounds, bis(μ‐3,5‐dichloro‐2‐oxidobenzoato)‐κ³O¹,O²:O²;κ³O²:O¹,O²‐bis[(3,5‐dichloro‐2‐hydroxybenzoic acid‐κO¹)(1,10‐phenanthroline‐κ²N,N′)copper(II)], [Cu₂(C₇H₂Cl₂O₃)₂(C₇H₄Cl₂O₃)₂(C₁₂H₈N₂)₂], (I), and bis(μ‐5‐chloro‐2‐oxidobenzoato)‐κ³O¹,O²:O¹;κ³O¹:O¹,O²‐bis[(5‐chloro‐2‐hydroxybenzoic acid‐κO¹)(1,10‐phenanthroline‐κ²N,N′)copper(II)] ethanol monosolvate, [Cu₂(C₇H₃ClO₃)₂(C₇H₅ClO₃)₂(C₁₂H₈N₂)₂]·C₂H₆O, (II), contain centrosymmetric dinuclear complex molecules in which Cu²⁺ cations are surrounded by a chelating 1,10‐phenanthroline ligand, a chelating 3,5‐dichloro‐2‐oxidobenzoate or 5‐chloro‐2‐oxidobenzoate anionic ligand and a monodentate 3,5‐dichloro‐2‐hydroxybenzoic acid or 5‐chloro‐2‐hydroxybenzoic acid ligand. The chelating benzoate ligand also bridges to the other Cu²⁺ ion in the molecule, but the O atom involved in the bridge is different in the two complexes, being the phenolate O atom in (I) and a carboxylate O atom in (II). The bridge completes a 4+1+1 axially elongated tetragonal–bipyramidal arrangement about each Cu²⁺ cation. The complex molecules of both compounds are linked into one‐dimensional supramolecular chains through O—H...O hydrogen bonds.